endocrinology

(redirected from endocrinologic)
Also found in: Dictionary, Thesaurus, Encyclopedia.

endocrinology

 [en″do-krĭ-nol´o-je]
1. the study of hormones, the endocrine system, and their role in the physiology of the body.
2. a medical specialty concerned with the diagnosis and treatment of disorders of the endocrine system.

en·do·cri·nol·o·gy

(en'dō-kri-nol'ŏ-jē),
The science and medical specialty concerned with the internal or hormonal secretions and their physiologic and pathologic relations.
[endocrine + G. logos, study]

endocrinology

(ĕn′də-krə-nŏl′ə-jē)
n.
The branch of medicine that deals with the diagnosis and treatment of diseases and disorders of the endocrine glands.

en′do·cri′no·log′ic (-krĭn′ə-lŏj′ĭk), en′do·crin′o·log′i·cal adj.
en′do·cri·nol′o·gist n.

endocrinology

The subspecialty of internal medicine dedicated to studying and managing diseases of the endocrine system–eg, conditions affecting the thyroid, adrenal glands, hypophysis and hypothalamic axes, ovaries, testes, pancreas. See Endocrine pancreas, Endocrinologist.

en·do·cri·nol·o·gy

(en'dō-kri-nol'ŏ-jē)
The science and medical specialty concerned with the internal or hormonal secretions and their physiologic and pathologic relations.
[endocrine + G. logos, study]

endocrinology

the study of ENDOCRINE GLANDS and their secretions.

en·do·cri·nol·o·gy

(en'dō-kri-nol'ŏ-jē)
Medical specialty concerned with internal or hormonal secretions and their physiologic and pathologic relations.
[endocrine + G. logos, study]
References in periodicals archive ?
(3,5) These associated adrenal pathologic conditions include adrenocortical hyperplasia, (3) adrenocortical adenomas, (3,5) adrenocortical carcinomas, (5) and endocrinologic dysfunctions, including Addison disease, (4) Conn syndrome, (5) 21-hydroxylase deficiency, (3) 17-hydroxylase deficiency, (6) and ectopic corticotropin production.
Caption: Members of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee in a panel meeting.
Causes Organic Anatomic * Infection * Uterine fibroids * Bleeding disorders * Endometrial polyps * Organ dysfunction * Endometrial hyperplasia * Pregnancy Endocrinologic Iatrogenic * Thyroid and adrenal * Intrauterine devices gland dysfunction * Steroid hormones * Pituitary tumors * Chemotherapy agents * Anovulatory cycles * Medications (eq.
FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 12 'yes', four 'no', and one abstention that AstraZeneca has established sufficient benefit to offset the observed risks to support the use of Crestor in men over 50 years and women over 60 years without history of cardiovascular or cerebrovascular events or coronary heart disease (CHD) risk equivalent as defined by NCEP ATP-III guidelines.
The recommendation by the FDA's endocrinologic and metabolic drugs advisory committee was also applauded by the American Association of Clinical Endocrinologists.
The text provides an overview of the physiologic and endocrinologic changes and the staging of perimenopause, as well as discussions of symptom management and preventive clinical practice.
Thyroid storm is a potentially life-threatening endocrinologic emergency characterized by an exacerbation of a hyperthyroid state.
The risk factors for nonoptimal periovulatory modulation of cervical liquefaction and oocyte maturation in humans are associated with high-risk conceptions related to compromised ovulation and/or fertilization: for example, nonoptimal maternal age and interpregnancy interval, specific seasons, endocrinologic disturbances, inadequate diet and socioeconomic status (SES), wars and other stressors, unhealthy lifestyle, and occupational burden (33).
It can best be described as a comprehensive up-to-date reference book on the subject of sports endocrinology and how exercise affects endocrinologic homeostasis.
Lexicon (LXRX) announced that the FDA Endocrinologic and Metabolic Drugs Advisory Committee, or EMDAC, plans to review Lexicon collaborator Sanofi's (SNY) new drug application, or NDA, for sotagliflozin, an investigational oral treatment for adults with type 1 diabetes, on January 17, 2019.
But the drug barely squeaked by its June FDA approval hearing for the cardioprotective indication, receiving a split 12-11 endorsement from the Endocrinologic and Metabolic Drugs Advisory Committee.
The company added that the 15-member panel of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) reportedly voted 12 to 2 (1 panelist did not vote) to approve the fixed-ratio combination of basal insulin glargine 100 Units/ml and GLP-1 receptor agonist lixisenatide.